Related references
Note: Only part of the references are listed.Precision Medicine in Lung Cancer Theranostics: Paving the Way from Traditional Technology to Advance Era
Xiaoyong Guan et al.
CANCER CONTROL (2022)
NSCLC as the Paradigm of Precision Medicine at Its Finest: The Rise of New Druggable Molecular Targets for Advanced Disease
Anna Michelotti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Targeting molecular alterations in non-small-cell lung cancer: what's next?
Rafael Lopez-Castro et al.
PERSONALIZED MEDICINE (2022)
Incorporating atezolizumab in the adjuvant setting of non-small cell lung cancer: key discussion points from an expert multidisciplinary panel by Italian Association of Thoracic Oncology
Filippo de Marinis et al.
FRONTIERS IN ONCOLOGY (2022)
Treating disease progression with osimertinib in EGFR-mutated non-small-cell lung cancer: novel targeted agents and combination strategies
V. Di Noia et al.
ESMO OPEN (2021)
Cancer incidence and cancer death in relation to tobacco smoking in a population-based Australian cohort study
Marianne F. Weber et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Achievement of long-term local control after radiation and anti-PD-1 immunotherapy in locally advanced non-small cell lung cancer
Zhao Jing et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2021)
The hazards of smoking and the benefits of cessation: a critical summation of the epidemiological evidence in high-income countries
Prabhat Jha
ELIFE (2020)
Immunotherapy Alone or in Combination with Chemotherapy as First-Line Treatment of Non-Small Cell Lung Cancer
Puneet Saxena et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2020)
Historical Changes in Histological Diagnosis of Lung Cancer
Mai Utada et al.
JOURNAL OF EPIDEMIOLOGY (2019)
First-line treatment for patients with advanced non-small cell lung carcinoma and high PD-L1 expression: pembrolizumab or pembrolizumab plus chemotherapy
Yixin Zhou et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Environmental and occupational determinants of lung cancer
Abhishek Shankar et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2019)
Air pollution and lung cancer incidence in China: Who are faced with a greater effect?
Huagui Guo et al.
ENVIRONMENT INTERNATIONAL (2019)
Lung Cancer Incidence in Nonmetropolitan and Metropolitan Counties - United States, 2007-2016
Mary Elizabeth O'Neil et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2019)
Lung cancer mortality and municipal marginalization in Mexico, 1998-2016
Laura Alejandra Ramirez-Tirado et al.
SALUD PUBLICA DE MEXICO (2019)
Heterogeneity in Lung Cancer
Vitor Manuel Leitao de Sousa et al.
PATHOBIOLOGY (2018)
International trends in lung cancer incidence from 1973 to 2007
Yue Zhang et al.
CANCER MEDICINE (2018)
Locally-advanced non-small cell lung cancer: shall immunotherapy be a new chance?
Andrea Riccardo Filippi et al.
JOURNAL OF THORACIC DISEASE (2018)
Lung cancer incidence trends in California by race/ethnicity, histology, sex, and neighborhood socioeconomic status: An analysis spanning 28 years
Manali I. Patel et al.
LUNG CANCER (2017)
Improvement of survival for non-small cell lung cancer over time
Wenjie Xia et al.
ONCOTARGETS AND THERAPY (2017)
Pembrolizumab as first-line therapy for patients with PD-L1-positive advanced non-small cell lung cancer: a phase 1 trial
R. Hui et al.
ANNALS OF ONCOLOGY (2017)
The effect of smoking on lung cancer: ethnic differences and the smoking paradox
Keum Ji Jung et al.
EPIDEMIOLOGY AND HEALTH (2016)
Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
H. Borghaei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Lung Cancer Incidence Trends by Gender, Race and Histology in the United States, 1973-2010
Rafael Meza et al.
PLOS ONE (2015)
Estimating and modeling relative survival
Paul W. Dickman et al.
STATA JOURNAL (2015)
Use of Multiple Imputation to Correct for Bias in Lung Cancer Incidence Trends by Histologic Subtype
Mandi Yu et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
Quitting Smoking Will Benefit Your Health: The Evolution of Clinician Messaging to Encourage Tobacco Cessation
Benjamin A. Toll et al.
CLINICAL CANCER RESEARCH (2014)
Lung cancer incidence in Singapore: Ethnic and gender differences
Wei-Yen Lim et al.
LUNG CANCER (2014)
The International Agency for Research on Cancer (IARC) evaluation of the carcinogenicity of outdoor air pollution: focus on China
Dana Loomis et al.
CHINESE JOURNAL OF CANCER (2014)
Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE)
Ole Raaschou-Nielsen et al.
LANCET ONCOLOGY (2013)
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
Denise R. Aberle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Effective inhibition of the epidermal growth factor/epidermal growth factor receptor binding by anti-epidermal growth factor antibodies is related to better survival in advanced non-small-cell lung cancer patients treated with the epidermal growth factor cancer vaccine
Beatriz Garcia et al.
CLINICAL CANCER RESEARCH (2008)
Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study
Neal D. Freedman et al.
LANCET ONCOLOGY (2008)
Comparison of aspects of smoking among the four histological types of lung cancer
S. A. Kenfield et al.
TOBACCO CONTROL (2008)
Ethnic and racial differences in the smoking-related risk of lung cancer
CA Haiman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Effect of smoking cessation on major histologic types of lung cancer
SA Khuder et al.
CHEST (2001)
Share Paper
